Delivery of a BET protein degrader via a CEACAM6-targeted antibody-drug conjugate inhibits tumour growth in pancreatic cancer models.
Nakazawa Y, Miyano M, Tsukamoto S, Kogai H, Yamamoto A, Iso K, Inoue S, Yamane Y, Yabe Y, Umihara H, Taguchi J, Akagi T, Yamaguchi A, Koga M, Toshimitsu K, Hirayama T, Mukai Y, Machinaga A.
Nakazawa Y, et al. Among authors: miyano m.
Nat Commun. 2024 Mar 11;15(1):2192. doi: 10.1038/s41467-024-46167-1.
Nat Commun. 2024.
PMID: 38467634
Free PMC article.